Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines
Clinical trial NCT05148000 · COMPLETED
Trial details
- NCT number
- NCT05148000
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2023-03-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.